SEC Company Response from IONIS PHARMACEUTICALS INC (IONS) (CIK 0000874015) (IONS) — Oct 31, 2005
IONIS PHARMACEUTICALS INC (IONS) (CIK 0000874015)
Date: Oct. 31, 2005 · CIK: 0000874015 · Accession: 0001104659-05-051142
AI Filing Summary & Sentiment
File numbers found in text: 333-128156
Letter
RE:
October 31, 2005
VIA FACSIMILE & EDGAR
Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, NW
Washington, DC 20549
Isis Pharmaceuticals, Inc.
Form S-3 Registration Statement No. 333-128156
Ladies and Gentlemen:
Pursuant to Rule 461 of Regulation C of the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Commission take appropriate action to cause the above-referenced Registration Statement No. 333-128156 to become effective at 5:00 p.m. Eastern Time on November 1, 2005 or as soon thereafter as is practicable.
In addition, the undersigned hereby acknowledges that:
• Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
• The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
• The company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
ISIS PHARMACEUTICALS, INC.
Show Raw Text
CORRESP 1 filename1.htm October 31, 2005 VIA FACSIMILE & EDGAR Securities and Exchange Commission Division of Corporation Finance 450 Fifth Street, NW Washington, DC 20549 RE: Isis Pharmaceuticals, Inc. Form S-3 Registration Statement No. 333-128156 Ladies and Gentlemen: Pursuant to Rule 461 of Regulation C of the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Commission take appropriate action to cause the above-referenced Registration Statement No. 333-128156 to become effective at 5:00 p.m. Eastern Time on November 1, 2005 or as soon thereafter as is practicable. In addition, the undersigned hereby acknowledges that: • Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; • The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and • The company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Very truly yours, ISIS PHARMACEUTICALS, INC. By: /s/ Patrick O’Neil Patrick O’Neil, Esq. Associate General Counsel cc: B. Lynne Parshall, Esq. Grantland E. Bryce, Esq.